Matches in Nanopublications for { ?s ?p "[Comparing tumours with low expression of CLDN3, CLDN4 and CLDN7 with tumours previously referred to as CLDN-low by genomic assays, we demonstrated that the single IHC evaluation of these three specific CLDNs is insufficient to identify the CLDN-low molecular subtype of breast tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- assertion description "[Comparing tumours with low expression of CLDN3, CLDN4 and CLDN7 with tumours previously referred to as CLDN-low by genomic assays, we demonstrated that the single IHC evaluation of these three specific CLDNs is insufficient to identify the CLDN-low molecular subtype of breast tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP641961.RA9Z9UzimQbG2D1AsktpDejSSLO9wMvB9XvA9zlc6aOnY130_assertion description "[Comparing tumours with low expression of CLDN3, CLDN4 and CLDN7 with tumours previously referred to as CLDN-low by genomic assays, we demonstrated that the single IHC evaluation of these three specific CLDNs is insufficient to identify the CLDN-low molecular subtype of breast tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641961.RA9Z9UzimQbG2D1AsktpDejSSLO9wMvB9XvA9zlc6aOnY130_provenance.
- NP651574.RANz9KO1al19FIImru2OIg8UeGRJAt7TLNmuPpCSmWEHU130_assertion description "[Comparing tumours with low expression of CLDN3, CLDN4 and CLDN7 with tumours previously referred to as CLDN-low by genomic assays, we demonstrated that the single IHC evaluation of these three specific CLDNs is insufficient to identify the CLDN-low molecular subtype of breast tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651574.RANz9KO1al19FIImru2OIg8UeGRJAt7TLNmuPpCSmWEHU130_provenance.
- NP1009276.RAsYTWo6kNe2ureiMzBH1xaa-JVr23OA2j0peRLUTstdM130_assertion description "[Comparing tumours with low expression of CLDN3, CLDN4 and CLDN7 with tumours previously referred to as CLDN-low by genomic assays, we demonstrated that the single IHC evaluation of these three specific CLDNs is insufficient to identify the CLDN-low molecular subtype of breast tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1009276.RAsYTWo6kNe2ureiMzBH1xaa-JVr23OA2j0peRLUTstdM130_provenance.
- NP323998.RALZ_IAGjQgd71Z1f-c7UDnc6LhiTyfkJXskpuxnFNKGg130_assertion description "[Comparing tumours with low expression of CLDN3, CLDN4 and CLDN7 with tumours previously referred to as CLDN-low by genomic assays, we demonstrated that the single IHC evaluation of these three specific CLDNs is insufficient to identify the CLDN-low molecular subtype of breast tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323998.RALZ_IAGjQgd71Z1f-c7UDnc6LhiTyfkJXskpuxnFNKGg130_provenance.
- NP324290.RAFcQEI_yZ2dtV5oZMxu8H6TFwnPp9vN_ddjlmHbcASTE130_assertion description "[Comparing tumours with low expression of CLDN3, CLDN4 and CLDN7 with tumours previously referred to as CLDN-low by genomic assays, we demonstrated that the single IHC evaluation of these three specific CLDNs is insufficient to identify the CLDN-low molecular subtype of breast tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324290.RAFcQEI_yZ2dtV5oZMxu8H6TFwnPp9vN_ddjlmHbcASTE130_provenance.
- NP1009275.RA3KLhReBiA8enNjth3ofizUooei2cVVLJKb_gAbdMXuM130_assertion description "[Comparing tumours with low expression of CLDN3, CLDN4 and CLDN7 with tumours previously referred to as CLDN-low by genomic assays, we demonstrated that the single IHC evaluation of these three specific CLDNs is insufficient to identify the CLDN-low molecular subtype of breast tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1009275.RA3KLhReBiA8enNjth3ofizUooei2cVVLJKb_gAbdMXuM130_provenance.